TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
08/02/2023
Back to search
Official data from USPTO
BRISTOL MYERS SQUIBB
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
43
Latest update
08/12/2023
Trademark type
Combined
Nice classes
5, 42
Filing date
11/22/2019
Registration date
04/12/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
04/12/2022
Last transaction
08/12/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
03/04/2020
First use in commerce
03/04/2020
Drawing code
3
Owner type
03
Owner location
Princeton, NJ, US
Examiner
MORRIS, ALINA S.
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of five vertical lines of varying lengths arranged next to each other resembling fingers on a hand where the first line curves at the bottom towards the right, positioned to the left of the words "BRISTOL MYERS SQUIBB".
Holders and representatives
Holders
Bristol-Myers Squibb Company
Bristol-Myers Squibb Company
Representatives
Marilyn F. Kelly Bristol-Myers Squibb Company
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for human use for the treatment and prevention of cardiovascular diseasescentral nervous system diseases and disordersstrokecancerinflammation and inflammatory diseasesrespiratory and infectious diseasesauto-immune diseasessolid organ transplant rejectionmyeloproliferative diseasesmyelofibrosisleukemialymphomamultiple myelomaautoinflammatory diseaseblood diseasetumorsmultiple sclerosisarthritis; Pharmaceutical preparations for human useantibioticsimmunosuppressantsimmunotherapies for the treatment of cancer; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical and biological preparations for human use for immunotherapyincluding T Cell therapy
Class 42
Pharmaceutical research and development services
Publications
History of USPTO decisions and trademark events.
43 publications found
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
08/02/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
08/02/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
08/02/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
08/02/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
04/12/2022
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/05/2022
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/04/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
02/19/2022
SUPC
STATEMENT OF USE PROCESSING COMPLETE
02/18/2022
EX2G
SOU EXTENSION 2 GRANTED
02/18/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/15/2022
INCE
ITU OFFICE ACTION ISSUED FOR EXTENSION REQUEST
02/09/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
02/09/2022
IUAF
USE AMENDMENT FILED
02/02/2022
EXT2
SOU EXTENSION 2 FILED
02/02/2022
EEXT
SOU TEAS EXTENSION RECEIVED
02/02/2022
EISU
TEAS STATEMENT OF USE RECEIVED
02/02/2022
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
08/04/2021
EX1G
SOU EXTENSION 1 GRANTED
08/02/2021
EXT1
SOU EXTENSION 1 FILED
08/02/2021
EEXT
SOU TEAS EXTENSION RECEIVED
08/02/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/02/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/08/2020
PUBO
PUBLISHED FOR OPPOSITION
12/08/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/18/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/29/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/29/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/29/2020
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
10/29/2020
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
05/05/2020
GNFR
FINAL REFUSAL E-MAILED
05/05/2020
CNFR
FINAL REFUSAL WRITTEN
05/05/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/21/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/21/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
04/21/2020
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
02/12/2020
GNRT
NON-FINAL ACTION E-MAILED
02/12/2020
CNRT
NON-FINAL ACTION WRITTEN
02/12/2020
DOCK
ASSIGNED TO EXAMINER
02/11/2020
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
12/03/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/01/2019
NWAP
NEW APPLICATION ENTERED
11/26/2019
Continuous trademark protection
Get notified about every new filing that threatens BRISTOL MYERS SQUIBB or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.